These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 24445080)
1. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080 [TBL] [Abstract][Full Text] [Related]
2. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease. Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073 [TBL] [Abstract][Full Text] [Related]
3. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease. Ginsberg SD; Alldred MJ; Che S Neurobiol Dis; 2012 Jan; 45(1):99-107. PubMed ID: 21821124 [TBL] [Abstract][Full Text] [Related]
4. Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability. He B; Perez SE; Lee SH; Ginsberg SD; Malek-Ahmadi M; Mufson EJ J Comp Neurol; 2020 Nov; 528(16):2748-2766. PubMed ID: 32323319 [TBL] [Abstract][Full Text] [Related]
5. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510 [TBL] [Abstract][Full Text] [Related]
6. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. Scheff SW; Price DA; Ansari MA; Roberts KN; Schmitt FA; Ikonomovic MD; Mufson EJ J Alzheimers Dis; 2015; 43(3):1073-90. PubMed ID: 25147118 [TBL] [Abstract][Full Text] [Related]
7. Hippocampal drebrin loss in mild cognitive impairment. Counts SE; He B; Nadeem M; Wuu J; Scheff SW; Mufson EJ Neurodegener Dis; 2012; 10(1-4):216-9. PubMed ID: 22310934 [TBL] [Abstract][Full Text] [Related]
8. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease. Berchtold NC; Sabbagh MN; Beach TG; Kim RC; Cribbs DH; Cotman CW Neurobiol Aging; 2014 Sep; 35(9):1961-72. PubMed ID: 24786631 [TBL] [Abstract][Full Text] [Related]
9. Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease. Kelly SC; He B; Perez SE; Ginsberg SD; Mufson EJ; Counts SE Acta Neuropathol Commun; 2017 Jan; 5(1):8. PubMed ID: 28109312 [TBL] [Abstract][Full Text] [Related]
10. Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease. Perez-Cruz C; Nolte MW; van Gaalen MM; Rustay NR; Termont A; Tanghe A; Kirchhoff F; Ebert U J Neurosci; 2011 Mar; 31(10):3926-34. PubMed ID: 21389247 [TBL] [Abstract][Full Text] [Related]
11. Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer's disease. Sri S; Pegasiou CM; Cave CA; Hough K; Wood N; Gomez-Nicola D; Deinhardt K; Bannerman D; Perry VH; Vargas-Caballero M Acta Neuropathol Commun; 2019 Feb; 7(1):25. PubMed ID: 30795807 [TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Alldred MJ; Duff KE; Ginsberg SD Neurobiol Dis; 2012 Feb; 45(2):751-62. PubMed ID: 22079237 [TBL] [Abstract][Full Text] [Related]
13. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD). Alldred MJ; Lee SH; Petkova E; Ginsberg SD Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177 [TBL] [Abstract][Full Text] [Related]
14. Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease. Ruiter M; Herstel LJ; Wierenga CJ J Alzheimers Dis; 2020; 78(3):951-964. PubMed ID: 33074225 [TBL] [Abstract][Full Text] [Related]
15. Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis. Hollnagel JO; Elzoheiry S; Gorgas K; Kins S; Beretta CA; Kirsch J; Kuhse J; Kann O; Kiss E PLoS One; 2019; 14(1):e0209228. PubMed ID: 30645585 [TBL] [Abstract][Full Text] [Related]
16. Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment. Regier M; Liang J; Choi A; Verma K; Libien J; Hernández AI Neural Plast; 2019; 2019():4383258. PubMed ID: 31827497 [TBL] [Abstract][Full Text] [Related]
17. CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation. Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD Hippocampus; 2018 Apr; 28(4):251-268. PubMed ID: 29394516 [TBL] [Abstract][Full Text] [Related]
18. Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice. Alldred MJ; Pidikiti H; Ibrahim KW; Lee SH; Heguy A; Hoffman GE; Mufson EJ; Stutzmann GE; Ginsberg SD J Alzheimers Dis; 2024; 100(s1):S341-S362. PubMed ID: 39031371 [TBL] [Abstract][Full Text] [Related]